X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4735) 4735
Publication (641) 641
Book Review (576) 576
Book Chapter (16) 16
Conference Proceeding (9) 9
Dissertation (3) 3
Book / eBook (2) 2
Magazine Article (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (4565) 4565
humans (3989) 3989
animals (2249) 2249
oncology (1848) 1848
proto-oncogene proteins c-met - genetics (1834) 1834
proto-oncogene proteins c-met - metabolism (1791) 1791
female (1539) 1539
mice (1442) 1442
c-met (1425) 1425
male (1328) 1328
cell line, tumor (1267) 1267
cancer (1186) 1186
expression (1006) 1006
signal transduction (994) 994
cell biology (987) 987
hepatocyte growth-factor (895) 895
middle aged (818) 818
biochemistry & molecular biology (794) 794
mutation (763) 763
aged (705) 705
hepatocyte growth factor - metabolism (704) 704
phosphorylation (697) 697
gene expression (645) 645
research (629) 629
tumors (619) 619
adult (615) 615
metastasis (601) 601
met (583) 583
gene expression regulation, neoplastic (569) 569
proto-oncogene proteins c-met - antagonists & inhibitors (556) 556
hepatocyte growth factor - genetics (547) 547
kinases (522) 522
immunohistochemistry (521) 521
apoptosis (516) 516
genetic aspects (511) 511
hepatocyte growth factor (489) 489
proteins (489) 489
proto-oncogene proteins - genetics (487) 487
activation (478) 478
proto-oncogene proteins c-met (473) 473
cell proliferation (468) 468
analysis (465) 465
prognosis (462) 462
lung neoplasms - genetics (450) 450
signal transduction - drug effects (440) 440
proto-oncogene proteins c-akt - metabolism (430) 430
article (419) 419
tyrosine kinase (415) 415
cell proliferation - drug effects (389) 389
hepatocyte growth factor - pharmacology (388) 388
antineoplastic agents - pharmacology (384) 384
receptor (382) 382
cells (376) 376
mice, nude (371) 371
receptor tyrosine kinase (359) 359
cells, cultured (356) 356
protein kinase inhibitors - pharmacology (356) 356
research article (351) 351
aged, 80 and over (349) 349
receptor protein-tyrosine kinases - genetics (349) 349
health aspects (347) 347
factor scatter factor (346) 346
tumor cells, cultured (346) 346
multidisciplinary sciences (340) 340
tyrosine (337) 337
proto-oncogene proteins - metabolism (336) 336
growth (333) 333
blotting, western (332) 332
growth-factor receptor (327) 327
lung neoplasms - pathology (320) 320
receptor, epidermal growth factor - genetics (320) 320
rats (317) 317
genetics & heredity (314) 314
xenograft model antitumor assays (313) 313
care and treatment (311) 311
neoplasm invasiveness (309) 309
lung cancer (306) 306
gene amplification (304) 304
hgf (302) 302
gene (300) 300
reverse transcriptase polymerase chain reaction (295) 295
cell line (294) 294
receptor, epidermal growth factor - metabolism (293) 293
growth factors (291) 291
pathology (291) 291
lung neoplasms - drug therapy (288) 288
scatter factor (284) 284
development and progression (282) 282
down-regulation (282) 282
amplification (279) 279
medicine (279) 279
rna, messenger - genetics (276) 276
physiological aspects (274) 274
carcinoma (270) 270
transfection (268) 268
antineoplastic agents - therapeutic use (267) 267
carcinoma, non-small-cell lung - genetics (265) 265
mutations (265) 265
cell movement (263) 263
phosphatidylinositol 3-kinases - metabolism (263) 263
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4641) 4641
Chinese (51) 51
Japanese (17) 17
French (15) 15
Russian (5) 5
German (3) 3
Spanish (3) 3
Hungarian (2) 2
Italian (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 6/2011, Volume 108, Issue 24, pp. 9951 - 9956
The tyrosine kinase c-Met promotes the formation and malignant progression of multiple cancers. It is well known that c-Met hyperactivation increases... 
Phenotypes | Cell growth | Hepatocytes | Somatic cells | Induced pluripotent stem cells | Neurons | Stem cells | Glioblastoma | Neural stem cells | Tumors | Cancer stem cell | Oct4 | Sox2 | Klf4 | Hepatocyte growth factor | CANCER-CELLS | MULTIDISCIPLINARY SCIENCES | FACTOR EXPRESSION | PROLIFERATION | TUMORIGENICITY | TUMOR-INITIATING CELLS | P53 | cancer stem cell | PATHWAY | hepatocyte growth factor | IN-VIVO | GROWTH-FACTOR | DIFFERENTIATION | Proto-Oncogene Proteins c-met - metabolism | Homeodomain Proteins - metabolism | Humans | Glycoproteins - metabolism | Peptides - genetics | Immunoblotting | Transplantation, Heterologous | Antigens, CD - genetics | Antigens, CD - metabolism | Cellular Reprogramming | SOXB1 Transcription Factors - metabolism | Neoplasms, Experimental - pathology | Octamer Transcription Factor-3 - genetics | Flow Cytometry | Peptides - metabolism | Glioblastoma - genetics | Neoplastic Stem Cells - metabolism | RNA Interference | SOXB1 Transcription Factors - genetics | Neoplasms, Experimental - genetics | Neoplastic Stem Cells - pathology | Glioblastoma - metabolism | Indoles - pharmacology | Gene Expression Regulation, Neoplastic - drug effects | Tumor Cells, Cultured | Glycoproteins - genetics | Nanog Homeobox Protein | Signal Transduction | Proto-Oncogene Proteins c-met - antagonists & inhibitors | Mice, SCID | Reverse Transcriptase Polymerase Chain Reaction | Sulfonamides - pharmacology | AC133 Antigen | Piperazines - pharmacology | Proto-Oncogene Proteins c-myc - metabolism | Homeodomain Proteins - genetics | Proto-Oncogene Proteins c-met - genetics | Phenotype | Animals | Glioblastoma - pathology | Octamer Transcription Factor-3 - metabolism | Mice | Proto-Oncogene Proteins c-myc - genetics | Neoplasms, Experimental - metabolism | Physiological aspects | Development and progression | Cellular signal transduction | Genetic aspects | Research | Glioblastoma multiforme | Protein kinases | Proteins | Signal transduction | Genotype & phenotype | Kinases | Gene expression | Cancer | Transcription factors | Tumor cells | DNA damage | Embryo cells | Tumorigenicity | neurospheres | Differentiation | Protein-tyrosine kinase | glioblastoma cells | Index Medicus | Biological Sciences
Journal Article
Cancer Research, ISSN 0008-5472, 06/2010, Volume 70, Issue 12, pp. 5184 - 5193
MicroRNAs (miRNA) have rapidly emerged as modulators of gene expression in cancer in which they may have great diagnostic and therapeutic import.... 
MIGRATION | INVASIVE GROWTH | INHIBITION | METASTASIS | THERAPY | ONCOLOGY | DOWN-REGULATION | HUMAN HEPATOCELLULAR-CARCINOMA | IDENTIFICATION | MICRORNA EXPRESSION | CANCER | Proto-Oncogene Proteins c-met - metabolism | Luciferases - metabolism | Antibiotics, Antineoplastic - pharmacology | Apoptosis - drug effects | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Drug Resistance, Neoplasm | Male | Intracellular Signaling Peptides and Proteins - metabolism | RNA, Messenger - metabolism | Carcinoma, Hepatocellular - drug therapy | Carcinoma, Hepatocellular - genetics | Aged, 80 and over | Female | Liver Neoplasms - pathology | Intracellular Signaling Peptides and Proteins - genetics | Liver Cirrhosis - genetics | Protein-Serine-Threonine Kinases - metabolism | Liver Cirrhosis - drug therapy | Liver Neoplasms - genetics | RNA, Messenger - genetics | Liver Neoplasms - drug therapy | Protein-Serine-Threonine Kinases - genetics | Cell Adhesion - drug effects | Reverse Transcriptase Polymerase Chain Reaction | Blotting, Western | Proto-Oncogene Proteins c-met - genetics | Cell Movement - drug effects | Carcinoma, Hepatocellular - pathology | Liver Cirrhosis - pathology | Aged | Cell Proliferation - drug effects | TOR Serine-Threonine Kinases | MicroRNAs - physiology | Cell Cycle - drug effects | Doxorubicin - pharmacology | Index Medicus
Journal Article
Nature Genetics, ISSN 1061-4036, 08/2012, Volume 44, Issue 8, pp. 852 - 860
Human non-small cell lung cancers (NSCLCs) with activating mutations in EGFR frequently respond to treatment with EGFRtargeted tyrosine kinase inhibitors... 
GEFITINIB | RECEPTOR TYROSINE KINASES | MET AMPLIFICATION | GROWTH | GENETICS & HEREDITY | ACQUIRED-RESISTANCE | MUTATIONS | NF-KAPPA-B | TUMORS | MUTANT EGFR | ERLOTINIB | Erlotinib Hydrochloride | Proto-Oncogene Proteins c-met - metabolism | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Humans | Lung Neoplasms - metabolism | Middle Aged | Lung Neoplasms - pathology | Male | Intercellular Signaling Peptides and Proteins - metabolism | Epithelial-Mesenchymal Transition | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Adult | Female | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Proto-Oncogene Proteins - metabolism | Proto-Oncogene Proteins - antagonists & inhibitors | Signal Transduction | Carcinoma, Non-Small-Cell Lung - genetics | Carcinoma, Non-Small-Cell Lung - metabolism | Intercellular Signaling Peptides and Proteins - genetics | Proto-Oncogene Proteins - genetics | Receptor Protein-Tyrosine Kinases - metabolism | Proto-Oncogene Proteins c-met - genetics | Xenograft Model Antitumor Assays | Drug Resistance, Neoplasm - genetics | Animals | Receptor Protein-Tyrosine Kinases - genetics | Cell Line, Tumor | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Protein Kinase Inhibitors - pharmacology | Carcinoma, Non-Small-Cell Lung - drug therapy | Enzyme Activation | Mutation | Quinazolines - pharmacology | Erlotinib | Physiological aspects | Genetic aspects | Research | Lung cancer, Non-small cell | Drug therapy | Health aspects | Protein kinases | Studies | Medical research | Rodents | Lung cancer | Genomics | Kinases | Gene expression | Acquisitions & mergers | Tumors | Index Medicus
Journal Article
Cancer Cell, ISSN 1535-6108, 05/2016, Volume 29, Issue 5, pp. 653 - 668
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 04/2013, Volume 19, Issue 7, pp. 1773 - 1783
Journal Article
Cancer Research, ISSN 0008-5472, 12/2010, Volume 70, Issue 24, pp. 10090 - 10100
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 05/2015, Volume 10, Issue 5, pp. 768 - 777
Journal Article
Oncotarget, ISSN 1949-2553, 2015, Volume 6, Issue 37, pp. 39756 - 39792
Hsa-miRNA-139-5p (miR-139-5p) has recently been discovered having anticancer efficacy in different organs. However, the role of miR-139-5p on lung cancer is... 
Hsa-miRNA-139-5p (miR-139-5p) | Proliferation | C-Met | Non-small cell lung cancer (NSCLC) | Apoptosis | Index Medicus
Journal Article
Nature Genetics, ISSN 1061-4036, 2015, Volume 47, Issue 1, pp. 13 - 21
Journal Article
International Journal of Cancer, ISSN 0020-7136, 09/2014, Volume 135, Issue 5, pp. 1110 - 1118
The importance of epigenetic modifications such as DNA methylation in tumorigenesis is increasingly being appreciated. To define the genome‐wide pattern of DNA... 
SLIT‐ROBO pathway | stellate cell activation | pancreatic cancer | axon‐guidance | methylation | SLIT-ROBO pathway | axon-guidance | ACTIVATION | HYPERMETHYLATION | MICROARRAY | CANCER | DISCOVERY | CDC42 | PATHWAY GENES | ONCOLOGY | TARGETS | R-PACKAGE | Epigenesis, Genetic | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Male | Gene Expression Profiling | Pancreatic Ducts - pathology | Integrins - metabolism | Promoter Regions, Genetic - genetics | Carcinoma, Pancreatic Ductal - genetics | RNA, Messenger - biosynthesis | DNA Methylation | Wnt Proteins - genetics | Base Sequence | Aged, 80 and over | Adult | Female | Pancreatic Stellate Cells - pathology | Cell Adhesion - genetics | Membrane Proteins - genetics | Intercellular Signaling Peptides and Proteins - genetics | Pancreatic Neoplasms - genetics | Signal Transduction - genetics | Nerve Tissue Proteins - genetics | Sequence Analysis, DNA | Proto-Oncogene Proteins c-met - genetics | Transforming Growth Factor beta - genetics | Integrin alpha2 - genetics | Aged | Receptors, Immunologic - genetics | Epigenetic inheritance | RNA | Genomics | Genomes | Gene expression | Promoters (Genetics) | Analysis | Pancreatic cancer | DNA | Genetic research | Bone morphogenetic proteins | Genetic aspects | Methylation | Integrins | Cancer | DNA methylation | Epigenetics | Deoxyribonucleic acid--DNA | Index Medicus
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 04/2011, Volume 103, Issue 8, pp. 645 - 661
Background Ionizing radiation (IR) is effectively used in cancer therapy. However, in subsets of patients, a few radioresistant cancer cells survive and cause... 
STEM-CELLS | IN-VITRO | ONCOLOGY | TYROSINE KINASE | HGF | CELL INVASION | RECEPTOR | EPITHELIAL-MESENCHYMAL TRANSITIONS | NF-KAPPA-B | SCATTER-FACTOR | PROTOONCOGENE | Humans | Neoplasm Invasiveness - prevention & control | Radiation Tolerance | Receptors, Growth Factor - antagonists & inhibitors | NF-kappa B - metabolism | RNA, Messenger - metabolism | NF-kappa B - radiation effects | Receptors, Growth Factor - genetics | Proto-Oncogene Proteins c-met - radiation effects | Signal Transduction - radiation effects | Protein-Serine-Threonine Kinases - metabolism | Radiation, Ionizing | Tumor Suppressor Proteins - metabolism | DNA-Binding Proteins - radiation effects | Proto-Oncogene Proteins c-met - antagonists & inhibitors | Cell Cycle Proteins - metabolism | Cell Cycle Proteins - radiation effects | Receptors, Growth Factor - radiation effects | Proto-Oncogene Proteins c-met - drug effects | Ataxia Telangiectasia Mutated Proteins | Phosphorylation - radiation effects | Cell Line, Tumor | Mice | RNA, Small Interfering | Tumor Suppressor Proteins - radiation effects | Receptors, Growth Factor - metabolism | Neoplasms - metabolism | Proto-Oncogene Proteins c-met - metabolism | Apoptosis - radiation effects | Up-Regulation - radiation effects | Transcription, Genetic - radiation effects | Transplantation, Heterologous | Sulfones - pharmacology | DNA-Binding Proteins - metabolism | Chromatin Immunoprecipitation | Protein-Serine-Threonine Kinases - radiation effects | Tumor Suppressor Proteins - genetics | Polymerase Chain Reaction | Cell Cycle Proteins - genetics | Indoles - pharmacology | Neoplasms - radiotherapy | Gene Expression Regulation, Neoplastic - drug effects | In Situ Nick-End Labeling | Enzyme-Linked Immunosorbent Assay | Radiation-Sensitizing Agents - pharmacology | Gene Silencing | Protein-Serine-Threonine Kinases - genetics | DNA-Binding Proteins - genetics | Cell Survival - radiation effects | Cell Movement - radiation effects | Proto-Oncogene Proteins c-met - genetics | Blotting, Northern | Animals | NF-kappa B - genetics | Protein Kinase Inhibitors - pharmacology | Neoplasms - pathology | Receptors, Growth Factor - drug effects | DNA Damage - radiation effects | Mitogen-Activated Protein Kinases - metabolism | Ionizing radiation | Physiological aspects | Genetic aspects | Cancer invasiveness | Research | Gene expression | Radiotherapy | Health aspects | Oncology | Radiation therapy | Kinases | Index Medicus
Journal Article